COM:CATALYSTPHARMA
Catalyst Pharmaceuticals, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
catalystpharma.comipo date
Nov 08, 2006
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi ...Show More